Ciclopirox Hydrolacquer Therapy For Adult Onychomycosis

Ciclopirox Hydrolacquer Therapy For Adult Onychomycosis Overview In a Phase III trial, a water-soluble ciclopirox nail hydrolacquer was evaluated for treating toenail fungal infection. Its enhanced penetration delivered higher ciclopirox concentration to the nail compared to existing lacquers. The study compared the hydrolacquer, its base formulation (vehicle), and an active control over

Onychomycosis And Diabetic Foot Syndrome

Onychomycosis And Diabetic Foot Syndrome Overview This systematic review aimed to investigate the prevalence of onychomycosis in individuals with diabetes and explore its connection to risk factors, particularly within the context of diabetic foot syndrome. Adhering to the PRISMA guidelines and utilizing the STROBE method, the study searched PubMed and Scopus databases

Pediatric Onychomycosis Prevalence: A Systematic Review

Pediatric Onychomycosis Prevalence: A Systematic Review Overview Onychomycosis, a prevalent nail ailment in adults, has historically been considered rare in children, despite scattered and diverse data. Recent studies, however, hint at an increasing prevalence of onychomycosis in children. This review aimed to address this issue, with two authors individually scouring PubMed, Embase,

Ciclopirox Hydrolacquer Therapy For Adult Onychomycosis